Long-Acting Injectables: Part 1 of a Conversation With Peter J. Weiden, MD

News
Article

Peter J. Weiden, MD, sat down with Psychiatric Times’ Editor-in-Chief at the 2024 Annual Meeting. Here’s Part 1 of their conversation.

CONFERENCE REPORTER
Psychiatric Times Editor-in-Chief, John J. Miller, MD, sat down with his colleague, Peter J. Weiden, MD, of the State University of New York at Stony Brook at the 2024 American Psychiatric Association (APA) Annual Meeting. In part 1 of their conversation, Miller and Weiden discuss long-acting injectables then and now.

Dr Weiden is a professor at the State University of New York at Stony Brook.

See more coverage from the 2024 APA Annual Meeting in Psychiatric Times at https://www.psychiatrictimes.com/conferences/apa.

Related Videos
ADHD
brain depression
brain
nicotine use
brain schizophrenia
eating disorder brain
dementia
schizophrenia
virtual conference
© 2024 MJH Life Sciences

All rights reserved.